ABBVIE INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.05 USD | +4.64% |
|
+6.18% | +18.75% |
| 06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
| 06-28 | AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment | MT |
Quotes 5-day view
End-of-day quote Buenos Aires S.E.| 25/06/2024 | 26/06/2024 | 27/06/2024 | |
|---|---|---|---|
| Last | 17.05 $ | 17.25 $ | 18.05 $ |
| Volume | 35 | 21 | 59 |
| Change | +∞% | +1.17% | +4.64% |
| Opening | 17.30 | 17.35 | 16.90 |
| High | 17.30 | 17.35 | 18.05 |
| Low | 17.00 | 17.25 | 16.90 |
Performance
| 1 day | +4.64% | ||
| 1 week | +6.18% | ||
| 1 month | +10.40% | ||
| 3 months | -5.99% | ||
| 6 months | +18.75% | ||
| Current year | +18.75% | ||
| 1 year | +22.79% |
Volumes
marketsDaily volume
59
Avg. Volume 20 sessions
37
Avg. Volume 20 sessions USD
667.85
Record volume 1
360
Record volume 2
332
Record volume 3
308
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
302 881 641 797
Net sales (USD)
54 318 000 000
Number of employees
50 000
Sales / Employee (USD)
1 086 360
Free-Float
96.38 %
Free-Float capitalization (USD)
302 537 547 807
Average Daily Capital Traded
0%
Highs and lows
1 week
16.90
18.05
1 month
16.2518.05
Current year
14.6520.00
1 year
13.0020.00
3 years
10.7520.00
5 years
10.7520.00
10 years
10.7520.00
Indicators
Moving average 5 days
17.31
Moving average 20 days
16.76
Moving average 50 days
17.46
Moving average 100 days
17.52
Price spread / (MMA5)
-4.10%
Price spread / (MMA20)
-7.15%
Price spread / (MMA50)
-3.27%
Price spread / (MMA100)
-2.94%
STIM
RSI 9 days
69.30
RSI 14 days
61.10
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +4.64% | +6.18% | +18.75% | +22.79% | 303B | ||
| -0.40% | +2.43% | +55.32% | +93.05% | 815B | ||
| -0.98% | +0.99% | +42.99% | +84.41% | 641B | ||
| +0.25% | -1.74% | -6.75% | -11.70% | 352B | ||
| -4.64% | -5.29% | +13.56% | +7.29% | 314B | ||
| -0.35% | -1.33% | +16.15% | +18.68% | 242B | ||
| -0.06% | -2.35% | +2.00% | -8.80% | 224B | ||
| +0.01% | +0.21% | +13.36% | +8.66% | 218B | ||
| -0.40% | +1.39% | +8.48% | +40.73% | 168B | ||
| +0.65% | +0.87% | -2.81% | -23.72% | 159B | ||
| +1.75% | +1.26% | +1.94% | -6.88% | 120B | ||
| -0.32% | -2.91% | -15.31% | -10.98% | 85.48B | ||
| +0.05% | -0.95% | -19.06% | -35.06% | 84.19B | ||
| -0.52% | -5.31% | +5.03% | +9.85% | 78.83B | ||
| -1.76% | -0.28% | +40.16% | +18.55% | 65.64B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| Average | +0.48% | -0.20% | +11.59% | +13.79% | ||
| Weighted average by Cap. | +0.55% | +0.29% | +22.95% | +36.13% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +18.75% | ||
| 2023 | -7.32% | ||
| 2022 | +18.84% | ||
| 2021 | +15.97% |
- Stock Market
- Equities
- ABBV Stock
- ABBVD Stock
- Quotes AbbVie Inc.
